Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	The Journal of Infection in Developing Countries 2024-05-01
Цуврал:	Journal of Infection in Developing Countries
Нөхцлүүд:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
Онлайн хандалт:	https://jidc.org/index.php/journal/article/view/18410
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!